Retrospective analysis of Hemoporfin-mediated photodynamic therapy in the treatment of naïve port-wine stains

Photodiagnosis Photodyn Ther. 2022 Sep:39:103003. doi: 10.1016/j.pdpdt.2022.103003. Epub 2022 Jul 13.

Abstract

Background: Hemoporfin-mediated photodynamic therapy (Hemoporfin-PDT) is a safe and effective treatment modality for port-wine stain (PWS). However, there is still no consensus about the influential factors for the efficacy of the treatment. This study investigated the influential factors associated with the efficacy of Hemoporfin-PDT.

Methods: We retrospectively analyzed 321 PWS patients who underwent Hemoporfin-PDT at our center from August 2017 to July 2021. The correlation between efficacy versus sex, age, location, type of PWS, treatment numbers, and the lesion size were analyzed.

Results: The numbers of treatment sessions undertaken were associated with the response to therapy, and compared with patients who received one session, patients who received two or more sessions showed a better response (ORadj=2.46, 95%CI, 1.49-4.07; ORadj=6.01, 95%CI, 3.38-10.70, P<0.001). The effect on central face, peripheral face, and neck was superior to the extremity and trunk, respectively (P<0.001). The lesion size smaller than and equal to 25 cm² showed a better effect than those whose lesion size was larger than 64 cm² (ORadj=1.92, 95%CI, 1.03-3.57, P=0.040). However, other variables, including sex and age, were not associated with the efficacy of the treatment.

Conclusions: Hemoporfin-PDT is an effective and safe treatment for PWS. The number of treatments was a favorable factor for Hemoporfin-PDT, smaller lesion sizes showed a better effect than the larger one, and the location of extremity and trunk was a negative factor.

Keywords: Efficacy; Hemoporfin-PDT; Influential factor.

MeSH terms

  • Hematoporphyrins
  • Humans
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use
  • Port-Wine Stain* / drug therapy
  • Port-Wine Stain* / pathology
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Hematoporphyrins
  • Photosensitizing Agents
  • hematoporphyrin monomethyl ether